Transcriptomics

Dataset Information

0

CITE-seq reveals inhibition of NF-kB pathway in B cells from vitamin D-treated multiple sclerosis patients


ABSTRACT: Vitamin D deficiency is a risk factor for multiple sclerosis (MS) and is correlated with disease activity and progression. Vitamin D treatment has emerged as potentially protective, even though results from randomized controlled trials are conflicting. Here, we used single-cell RNA-seq (scRNA-seq) coupled with barcoded antibodies targeting surface markers (CITE-seq) to discover candidate genes and pathways regulated in PBMC subpopulations from MS patients treated with high-dose vitamin D (n=5) or placebo (n=5). Best candidates were combined with genes involved in immune function and vitamin D metabolism for validation in a new cohort (n=8 in each group) by high-throughput qPCR (HT-qPCR) in naive CD4, Th1, Th17, Treg, naive CD8, memory and naive B cells, and MAIT cells, sorted by FACS. CITE-seq showed no significant changes in the proportions of these subpopulations in vitamin D-treated patients. Of the 92 candidate genes revealed by CITE-seq, differential expression of five genes (UXT, SNRPN, SUB1, GNLY and KLF6) was validated by HT-qPCR. CITE-seq also revealed the regulation of several pathways by vitamin D in naive and memory B cells, including MAPK, TLR and interleukin pathways, that contribute to counteract EBV-induced resistance to apoptosis through inhibition of the NF-kB pathway.

ORGANISM(S): Homo sapiens

PROVIDER: GSE239626 | GEO | 2023/10/05

REPOSITORIES: GEO

Similar Datasets

2024-05-01 | GSE202403 | GEO
| PRJNA795192 | ENA
2024-05-18 | GSE175928 | GEO
2020-07-06 | E-MTAB-9295 | biostudies-arrayexpress
2016-05-11 | GSE75217 | GEO
| EGAS00001007254 | EGA
| EGAS00001007346 | EGA
2024-04-18 | E-MTAB-13721 | biostudies-arrayexpress
2022-04-29 | GSE174771 | GEO
2020-08-07 | GSE143281 | GEO